MeiraGTx Holdings (MGTX) Preferred Dividend Payments (2017 - 2018)
MeiraGTx Holdings' (MGTX) quarterly Preferred Dividend Payments came in at $1.1 million in Q2 2018, up 3655.78% YoY from $30401.0 in Q2 2017, and up 71.77% on a QoQ basis from $664718.0 in Q1 2018.
Powered by 
Analysis
MeiraGTx Holdings (MGTX) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
MeiraGTx Holdings (MGTX) has 2 years of Preferred Dividend Payments data on file, last reported at $1.1 million in Q2 2018.
- Quarterly Preferred Dividend Payments rose 3655.78% year-over-year to $1.1 million in Q2 2018, while the trailing twelve-month figure through Dec 2018 was $1.8 million (changed N/A YoY) and the FY2018 annual result came in at $1.8 million, up 123.87% from the prior year.
- Preferred Dividend Payments advanced to $1.1 million in Q2 2018, from $664718.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $1.1 million in Q2 2018 to a low of $30401.0 in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 1.14 Mn |
| Mar 31, 2018 | 664,718.00 |
| Dec 31, 2017 | 562,043.00 |
| Sep 30, 2017 | 191,758.00 |
| Jun 30, 2017 | 30,401.00 |